Nelarabine

Nelarabine

SCHEMBL20769831

COc1nc(N)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O.COc1nc(N)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ CYP2C19 P33261 1/20 0.71
▸ ADORA2A P29274 3/20 0.70
▸ ADORA3 P0DMS8 2/20 0.70
▸ ADORA1 P30542 2/20 0.70
▸ ADORA2B P29275 2/20 0.70
▸ SLC29A1 Q99808 5/20 0.67
▸ PGK1 P00558 1/20 0.64
▸ PGK2 P07205 1/20 0.64
▸ LMNA P02545 1/20 0.61
▸ NT5E P21589 1/20 0.61
▸ HIF1A Q16665 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nelarabine SCHEMBL31326718 1.00 CYP2C19 (0.71) CYP2C19ADORA2AADORA3ADORA1ADORA2B
Nelarabine SCHEMBL1818971 1.00 CYP2C19 (0.71) CYP2C19ADORA2AADORA3ADORA1ADORA2B
Nelarabine SCHEMBL18321891 1.00 CYP2C19 (0.71) CYP2C19ADORA2AADORA3ADORA1ADORA2B
Nelarabine SCHEMBL2143756 1.00 CYP2C19 (0.71) CYP2C19ADORA2AADORA3ADORA1ADORA2B
Nelarabine SCHEMBL14031852 1.00 CYP2C19 (0.71) CYP2C19ADORA2AADORA3ADORA1ADORA2B
Nelarabine SCHEMBL9937290 1.00 CYP2C19 (0.71) CYP2C19ADORA2AADORA3ADORA1ADORA2B
Nelarabine SCHEMBL13575801 1.00 CYP2C19 (0.71) CYP2C19ADORA2AADORA3ADORA1ADORA2B
Nelarabine SCHEMBL13657986 1.00 CYP2C19 (0.71) CYP2C19ADORA2AADORA3ADORA1ADORA2B
Nelarabine SCHEMBL18820 1.00 CYP2C19 (0.71) CYP2C19ADORA2AADORA3ADORA1ADORA2B
Nelarabine SCHEMBL29077509 1.00 CYP2C19 (0.71) CYP2C19ADORA2AADORA3ADORA1ADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3675838-A1 LYMPHATIC SYSTEM-DIRECTING LIPID PRODRUGS Puretecch LYT, Inc. (US) 2020-07-08 — — EP disclosed
WO-2019046491-A1 LYMPHATIC SYSTEM-DIRECTING LIPID PRODRUGS ARIYA THERAPEUTICS, INC. (US) 2019-03-07 — — WO disclosed
Send feedback